Broad-spectrum tetracyclinePHOTOTOXICITY

Doxycycline

Doxyferm · Doxycyklin EQL Pharma · Vibranord

The tetracycline that covers both respiratory pathogens and the intracellular organisms that beta-lactams miss — Mycoplasma pneumoniae, Chlamydophila, and Borrelia. Near-complete oral absorption and a long half-life make once-daily dosing possible. It is the standard choice in pneumonia in penicillin-allergic patients and in atypical pneumonia, but the age limit of 8 years and pregnancy significantly restrict use.

BOXED WARNING

Not given to children under 8 years or in the second half of pregnancy — tetracyclines bind to mineralising tooth substance and cause enamel hypoplasia and permanent discoloration. In these patients, amoxicillin or phenoxymethylpenicillin is used for Borrelia and erythromycin for atypical pneumonia.

Dosing in adults

By indicationuppdaterad 2026-08-22
IndicationRegimenComment
Pneumonia in penicillin-allergic patients200 mg × 1 orally for 3 days, then 100 mg × 1 — total 7 dayscovers both pneumococci and atypical organisms
Atypical pneumonia (Mycoplasma, Chlamydophila)200 mg × 1 orally days 1–3, then 100 mg × 1 — total 7–10 daysfirst-line choice in adults and children over 8 years
Erythema migrans100 mg × 2 orally for 10 daysfor solitary EM, phenoxymethylpenicillin 1 g × 3 for 10 days is first-line choice
Multiple erythema migrans, Borrelia lymphocytoma, neuroborreliosis200 mg × 1 orally for 10–14 daysoral doxycycline is equivalent to intravenous ceftriaxone in early neuroborreliosis
COPD exacerbation with treatment indication200 mg × 1 orally day 1, then 100 mg × 1 — total 5–7 dayscovers Haemophilus influenzae and Moraxella
Renal impairment

No dose adjustment at any level of renal function — largely eliminated via the gut and does not accumulate. This is a practical advantage in patients with renal failure where other alternatives require dose modification.

Hepatic impairment

Use with caution in severe hepatic failure and avoid concurrent hepatotoxic drugs. No established dose reduction.

Children

Children 8 years and older: 4 mg/kg × 1 day 1 (maximum 200 mg), then 2 mg/kg × 1 (maximum 100 mg). In neuroborreliosis 4 mg/kg × 1 for 10–14 days. Contraindicated below age 8.

Pitfall

Wrong choice for lower urinary tract infection — urinary concentration is low and E. coli resistance is high. Also avoid in pregnancy and in children under 8 years, and never take the tablet lying down or without fluid: doxycycline is one of the most common causes of drug-induced oesophageal ulceration.

Pharmacokinetics

BIOAVAIL.
approximately 93 % orally
18–22 hours
PROTEIN BINDING
80–90 %
METABOLISM
Negligible
EXCRETION
Renal approximately 40 %, remainder via the gut
FOOD EFFECT
Calcium, iron, and antacids chelate and abolish absorption
CNS PENETRATION
Good — adequate for neuroborreliosis
ONSET
Therapeutic level within 30 minutes

Adverse effects by frequency

≥ 10 %
Nausea, dyspepsia, diarrhoea, phototoxic skin reaction
1–10 %
Oesophagitis and oesophageal ulceration, rash, candidiasis, headache
< 1 %
Benign intracranial hypertension, Clostridioides difficile colitis, hepatotoxicity, DRESS